1. Home
  2. AUTL vs EU Comparison

AUTL vs EU Comparison

Compare AUTL & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUTL
  • EU
  • Stock Information
  • Founded
  • AUTL 2014
  • EU 2009
  • Country
  • AUTL United Kingdom
  • EU United States
  • Employees
  • AUTL N/A
  • EU N/A
  • Industry
  • AUTL Biotechnology: Biological Products (No Diagnostic Substances)
  • EU Other Metals and Minerals
  • Sector
  • AUTL Health Care
  • EU Basic Materials
  • Exchange
  • AUTL Nasdaq
  • EU Nasdaq
  • Market Cap
  • AUTL 590.8M
  • EU 669.1M
  • IPO Year
  • AUTL 2018
  • EU N/A
  • Fundamental
  • Price
  • AUTL $2.37
  • EU $3.56
  • Analyst Decision
  • AUTL Strong Buy
  • EU Strong Buy
  • Analyst Count
  • AUTL 3
  • EU 2
  • Target Price
  • AUTL $10.20
  • EU $6.50
  • AVG Volume (30 Days)
  • AUTL 1.2M
  • EU 1.4M
  • Earning Date
  • AUTL 03-13-2025
  • EU 11-14-2024
  • Dividend Yield
  • AUTL N/A
  • EU N/A
  • EPS Growth
  • AUTL N/A
  • EU N/A
  • EPS
  • AUTL N/A
  • EU N/A
  • Revenue
  • AUTL $10,091,000.00
  • EU $44,972,063.00
  • Revenue This Year
  • AUTL $851.83
  • EU N/A
  • Revenue Next Year
  • AUTL $264.18
  • EU $55.73
  • P/E Ratio
  • AUTL N/A
  • EU N/A
  • Revenue Growth
  • AUTL 82.71
  • EU N/A
  • 52 Week Low
  • AUTL $2.07
  • EU $3.02
  • 52 Week High
  • AUTL $7.37
  • EU $5.05
  • Technical
  • Relative Strength Index (RSI)
  • AUTL 46.88
  • EU 53.61
  • Support Level
  • AUTL $2.12
  • EU $3.26
  • Resistance Level
  • AUTL $2.38
  • EU $3.46
  • Average True Range (ATR)
  • AUTL 0.13
  • EU 0.19
  • MACD
  • AUTL 0.02
  • EU 0.03
  • Stochastic Oscillator
  • AUTL 37.23
  • EU 54.24

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

About EU enCore Energy Corp.

enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's material properties and projects are the Rosita Project located in Texas, the Alta Mesa Uranium project in Texas, the Crownpoint and Hosta Butte Uranium Project located in New Mexico, the Dewey Burdock Project located in South Dakota, and the Gas Hills Project located in Wyoming.

Share on Social Networks: